JB Chemicals & Pharmaceuticals Limited
3,496words
0turns
0analyst exchanges
0executives
Key numbers — 40 extracted
rs,
ironment. Forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause the actual results, financial condition, performance or achievements of the Company
50%
ross multiple businesses Brands among top 300 brands (IQVIA MAT Sep’25 data), contributing over 50% of domestic formulations revenues Regulated/semi-regulated markets of presence through direct o
28%
butors Global manufacturer of medicated/herbal lozenges representing a substantial opportunity 28% 2600+ 8 32% Growth in chronic therapies* in the domestic formulations business Strong India
32%
manufacturer of medicated/herbal lozenges representing a substantial opportunity 28% 2600+ 8 32% Growth in chronic therapies* in the domestic formulations business Strong India sales team# wit
21.3%
hot – Financial Overview Revenue (INR cr) PAT (INR cr) ^Op EBITDA Margin (%) ROE (%) ROCE (%) 21.3% 18.6% 1,643 1,775 15.4% 1,413 139 194 272 27.4% 25.0% 24.3% 27.0% 27.7% 3,918 3,484
18.6%
inancial Overview Revenue (INR cr) PAT (INR cr) ^Op EBITDA Margin (%) ROE (%) ROCE (%) 21.3% 18.6% 1,643 1,775 15.4% 1,413 139 194 272 27.4% 25.0% 24.3% 27.0% 27.7% 3,918 3,484 3,149
15.4%
venue (INR cr) PAT (INR cr) ^Op EBITDA Margin (%) ROE (%) ROCE (%) 21.3% 18.6% 1,643 1,775 15.4% 1,413 139 194 272 27.4% 25.0% 24.3% 27.0% 27.7% 3,918 3,484 3,149 2,424 2,043 449 3
27.4%
^Op EBITDA Margin (%) ROE (%) ROCE (%) 21.3% 18.6% 1,643 1,775 15.4% 1,413 139 194 272 27.4% 25.0% 24.3% 27.0% 27.7% 3,918 3,484 3,149 2,424 2,043 449 386 410 553 660 42% 25%
25.0%
ITDA Margin (%) ROE (%) ROCE (%) 21.3% 18.6% 1,643 1,775 15.4% 1,413 139 194 272 27.4% 25.0% 24.3% 27.0% 27.7% 3,918 3,484 3,149 2,424 2,043 449 386 410 553 660 42% 25% 29% 19
24.3%
rgin (%) ROE (%) ROCE (%) 21.3% 18.6% 1,643 1,775 15.4% 1,413 139 194 272 27.4% 25.0% 24.3% 27.0% 27.7% 3,918 3,484 3,149 2,424 2,043 449 386 410 553 660 42% 25% 29% 19% 32%
27.0%
) ROE (%) ROCE (%) 21.3% 18.6% 1,643 1,775 15.4% 1,413 139 194 272 27.4% 25.0% 24.3% 27.0% 27.7% 3,918 3,484 3,149 2,424 2,043 449 386 410 553 660 42% 25% 29% 19% 32% 27% 2
27.7%
(%) ROCE (%) 21.3% 18.6% 1,643 1,775 15.4% 1,413 139 194 272 27.4% 25.0% 24.3% 27.0% 27.7% 3,918 3,484 3,149 2,424 2,043 449 386 410 553 660 42% 25% 29% 19% 32% 27% 22% #
Advertisement